Dr. Xavier Molina, head of Promotion of Clinical Trials and Clinical Research at Vall d’Hebron Institute of Research (VHIR), participates in the report "http://www.correofarmaceutico.com/2013/09/02/areas-profesionales/farmacia-de-la-industria/rblockbusterr-del-manana" "http://www.correofarmaceutico.com/2013/09/02/areas-profesionales/farmacia-de-la-industria/rblockbusterr-del-manana" "The blockbusters of the future", published in Correo Farmacéutico and focused on the future of Research and Development (RD) in the pharmaceutical sector. The report analyzes the therapeutic areas which will bring more results during the following 5 years, and is based in a recent report of the Evaluate Pharma consultant which predicts that the pharmaceutical industry will start its economic recovery on 2014, with a sustained growth between the 4 and 5%. According to Dr. Molina, among the most promising areas are oncology, infectious diseases, neurology and orphan diseases. At the same time, he highlights in the article the great advance which is being carried out in treatments against multiple sclerosis and hepatitis C, thanks to the introduction of new molecules which are changing the development of these diseases.Nonetheless, experts interviewed in the report assure that more changes are needed in RD, manufacture and distribution, in order to provide more effective and efficient solutions.